These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 1545377
1. Predictability of the in vivo metabolism of verapamil from in vitro data: contribution of individual metabolic pathways and stereoselective aspects. Kroemer HK, Echizen H, Heidemann H, Eichelbaum M. J Pharmacol Exp Ther; 1992 Mar; 260(3):1052-7. PubMed ID: 1545377 [Abstract] [Full Text] [Related]
2. Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats. Hanada K, Ikemi Y, Kukita K, Mihara K, Ogata H. Drug Metab Dispos; 2008 Oct; 36(10):2037-42. PubMed ID: 18617604 [Abstract] [Full Text] [Related]
3. Regiochemistry and enantioselectivity in the oxidative N-dealkylation of verapamil. Nelson WL, Olsen LD. Drug Metab Dispos; 1988 Oct; 16(6):834-41. PubMed ID: 2907462 [Abstract] [Full Text] [Related]
4. Inhibition of the enantioselective oxidative metabolism of metoprolol by verapamil in human liver microsomes. Kim M, Shen DD, Eddy AC, Nelson WL, Roskos LK. Drug Metab Dispos; 1993 Oct; 21(2):309-17. PubMed ID: 8097702 [Abstract] [Full Text] [Related]
5. In vitro identification of metabolites of verapamil in rat liver microsomes. Sun L, Zhang SQ, Zhong DF. Acta Pharmacol Sin; 2004 Jan; 25(1):121-8. PubMed ID: 14704133 [Abstract] [Full Text] [Related]
8. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites. Botsch S, Gautier JC, Beaune P, Eichelbaum M, Kroemer HK. Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765 [Abstract] [Full Text] [Related]
12. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes. Echizen H, Mochizuki K, Tani M, Ishizaki T. J Pharmacol Exp Ther; 1994 Mar; 268(3):1518-25. PubMed ID: 8138963 [Abstract] [Full Text] [Related]
13. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Labroo RB, Paine MF, Thummel KE, Kharasch ED. Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623 [Abstract] [Full Text] [Related]
17. Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action. Mikus G, Eichelbaum M, Fischer C, Gumulka S, Klotz U, Kroemer HK. J Pharmacol Exp Ther; 1990 Jun; 253(3):1042-8. PubMed ID: 2359015 [Abstract] [Full Text] [Related]
18. Identification of P450 enzymes involved in metabolism of verapamil in humans. Kroemer HK, Gautier JC, Beaune P, Henderson C, Wolf CR, Eichelbaum M. Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):332-7. PubMed ID: 8232610 [Abstract] [Full Text] [Related]
20. In vivo and in vitro stereoselective metabolism of mianserin in mice. Heinig R, Blaschke G. Arzneimittelforschung; 1993 Jan; 43(1):5-10. PubMed ID: 8447847 [Abstract] [Full Text] [Related] Page: [Next] [New Search]